Rivaroxaban versus Warfarin in the Management of Deep Venous Thrombosis

ConclusionWe concluded in patients with unprovoked VTE, rivaroxaban has the potential to reduce both the risk of major bleeding and recurrent VTE compared to warfarin. And there ’s no need for adjusting the dose and INR monitoring, and Rivaroxaban has no food nor drug interactions.
Source: QJM - Category: Internal Medicine Source Type: research